Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124156213 | 12415621 | 3 | F | 20160419 | 20160801 | 20160530 | 20160809 | PER | US-PFIZER INC-2016253777 | PFIZER | 72.00 | YR | M | Y | 88.00000 | KG | 20160809 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124156213 | 12415621 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 1X/DAY | Y | 20235 | 300 | MG | CAPSULE, HARD | QD | ||||||
| 124156213 | 12415621 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 2X/DAY | Y | 20235 | 300 | MG | CAPSULE, HARD | BID | |||||
| 124156213 | 12415621 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 1X/DAY (FOR 3 DAYS ) | Y | 20235 | 300 | MG | CAPSULE, HARD | QD | ||||||
| 124156213 | 12415621 | 4 | SS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 2X/DAY (FOR 3 DAYS) | Y | 20235 | 300 | MG | CAPSULE, HARD | BID | ||||||
| 124156213 | 12415621 | 5 | SS | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, 3X/DAY | Y | 20235 | 300 | MG | CAPSULE, HARD | TID | ||||||
| 124156213 | 12415621 | 6 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG, ONE TABLET A DAY, EVERYDAY | 0 | 81 | MG | TABLET | QD | |||||||
| 124156213 | 12415621 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | 5 MG, 1X/DAY | 0 | 5 | MG | QD | ||||||||
| 124156213 | 12415621 | 8 | C | AMIODARONE | AMIODARONE | 1 | 200 MG, ONE A DAY | 0 | 200 | MG | QD | ||||||||
| 124156213 | 12415621 | 9 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | 20 MG, ONE A DAY | 0 | 20 | MG | QD | ||||||||
| 124156213 | 12415621 | 10 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, 1X/DAY | 0 | 75 | MG | QD | ||||||||
| 124156213 | 12415621 | 11 | C | Metoprolol XL | METOPROLOL SUCCINATE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 124156213 | 12415621 | 12 | C | ATORVASTATIN | ATORVASTATIN | 1 | 80 MG, 1X/DAY | 0 | 80 | MG | QD | ||||||||
| 124156213 | 12415621 | 13 | C | WARFARIN | WARFARIN | 1 | 3 MG, 1X/DAY | 0 | 3 | MG | QD | ||||||||
| 124156213 | 12415621 | 14 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 650 UG, UNK | 0 | 650 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124156213 | 12415621 | 1 | Neuralgia |
| 124156213 | 12415621 | 2 | Stenosis |
| 124156213 | 12415621 | 6 | Cardiac disorder |
| 124156213 | 12415621 | 9 | Antidepressant therapy |
| 124156213 | 12415621 | 10 | Antidepressant therapy |
| 124156213 | 12415621 | 11 | Cardiac disorder |
| 124156213 | 12415621 | 13 | Anticoagulant therapy |
| 124156213 | 12415621 | 14 | Thyroid disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124156213 | 12415621 | Condition aggravated | |
| 124156213 | 12415621 | Drug ineffective for unapproved indication | |
| 124156213 | 12415621 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124156213 | 12415621 | 1 | 20160419 | 0 | ||
| 124156213 | 12415621 | 2 | 20160422 | 0 | ||
| 124156213 | 12415621 | 4 | 20160422 | 0 | ||
| 124156213 | 12415621 | 8 | 20160627 | 0 |